Luveris (lutropin alfa) is a protein pharmaceutical. Lutropin alfa was first approved as Luveris on 2000-11-29. It is used to treat female infertility in the USA. It has been approved in Europe to treat female infertility and ovulation induction. The pharmaceutical is active against lutropin-choriogonadotropic hormone receptor.
|Common Name||Lutropin alfa|
|Indication||female infertility, ovulation induction|
|Drug Class||Tricyclic compounds; atropine derivatives|